Handelsbanken Fonder AB - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$280,000
-24.3%
9,0090.0%0.00%0.0%
Q1 2022$370,000
-5.6%
9,0090.0%0.00%0.0%
Q4 2021$392,000
-13.1%
9,0090.0%0.00%0.0%
Q3 2021$451,000
-20.5%
9,0090.0%0.00%
-33.3%
Q2 2021$567,000
-20.8%
9,009
+16.9%
0.00%
-25.0%
Q1 2021$716,000
+3.6%
7,7090.0%0.00%0.0%
Q4 2020$691,000
-13.3%
7,7090.0%0.00%
-33.3%
Q3 2020$797,000
-34.7%
7,709
-50.0%
0.01%
+20.0%
Q2 2020$1,220,00015,4180.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders